KAUST researchers have identified the gene 'CIROZ' as responsible for pediatric heart defects and misplacement of internal organs, working with institutes in Saudi Arabia and worldwide. The research examined samples from 16 patients from 10 families, including four from Saudi Arabia, revealing CIROZ's role in embryonic development symmetry. The findings provide insights into heritable diseases, which are more prevalent in Saudi Arabia. Why it matters: Identifying this gene allows for focused research on preventative strategies and curative therapies for congenital heart defects, particularly relevant in regions with higher rates of such diseases.
MBZUAI and Corniche Hospital researchers have developed FetalCLIP, a foundation model for analyzing fetal ultrasound images to detect congenital conditions. FetalCLIP outperformed other foundation models on ultrasound analysis tasks. The AI model aims to improve the early diagnosis of ailments like congenital heart defects. Why it matters: This innovation has the potential to dramatically improve health outcomes for millions of children annually by providing physicians with better insights into fetal health.
Researchers from MBZUAI have developed EchoCoTr, a novel spatiotemporal deep learning method for estimating left ventricular ejection fraction (LVEF) from echocardiograms. EchoCoTr combines CNNs and vision transformers to overcome the limitations of each when applied to medical video data. The method achieves state-of-the-art results on the EchoNet-Dynamic dataset, demonstrating improved accuracy compared to existing approaches, with code available on GitHub.
This paper introduces BRIQA, a new method for automated assessment of artifact severity in pediatric brain MRI, which is important for diagnostic accuracy. BRIQA uses gradient-based loss reweighting and a rotating batching scheme to handle class imbalance in artifact severity levels. Experiments show BRIQA improves average macro F1 score from 0.659 to 0.706, especially for Noise, Zipper, Positioning and Contrast artifacts.
MBZUAI researchers developed a new deep learning method for rapid and accurate estimation of clinical measurements from echocardiograms. The method focuses on improving the measurement of the left ventricle ejection fraction, a key indicator of heart health. Their deep learning approach improves upon previous methods by better organizing data representation, enhancing performance and transferability. Why it matters: The AI-driven solution can potentially reduce analysis time for cardiologists, improve patient care, and be particularly beneficial in regions with limited healthcare resources.
MBZUAI researchers led by Dr. Mohammad Yaqub are developing AI algorithms for real-time medical diagnoses, including tools for multiple sclerosis and congenital heart disease. The team developed ScanNav, an AI fetal anomaly assessment system licensed by GE Healthcare for Voluson SWIFT ultrasound machines. ScanNav assists doctors during anomaly scans after 20 weeks of gestation to check for conditions like heart issues and spina bifida. Why it matters: This research has the potential to significantly improve the speed and accuracy of medical diagnoses in the UAE and beyond, addressing critical gaps in healthcare.
This paper introduces a self-supervised contrastive learning method for segmenting the left ventricle in echocardiography images when limited labeled data is available. The approach uses contrastive pretraining to improve the performance of UNet and DeepLabV3 segmentation networks. Experiments on the EchoNet-Dynamic dataset show the method achieves a Dice score of 0.9252, outperforming existing approaches, with code available on Github.